⌘K

Login Start Free

Home/Filings/4/0000950170-25-109767

4//SEC Filing

Elazzouzi Amy 4

Accession 0000950170-25-109767

CIK 0001501796other

View on SEC.gov Company Profile

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 4:34 PM ET

Size

29.1 KB

Accession

0000950170-25-109767

Insider Transaction Report

Form 4

Period: 2025-08-18

Aura Biosciences, Inc.AURA

Senior Vice President, Finance

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2025-08-18−547→ 0 total
Exercise: $5.21Exp: 2027-04-12→ Common Stock (547 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-08-18−1,094→ 0 total
Exercise: $3.16Exp: 2029-02-06→ Common Stock (1,094 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-08-18−2,319→ 0 total
Exercise: $4.25Exp: 2030-03-16→ Common Stock (2,319 underlying)
Exercise/Conversion
Common Stock
2025-08-18$4.25/sh+2,319$9,856→ 94,280 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-08-18−2,554→ 0 total
Exercise: $5.07Exp: 2025-09-03→ Common Stock (2,554 underlying)
Exercise/Conversion
Common Stock
2025-08-18$5.48/sh+1,094$5,995→ 85,029 total
Exercise/Conversion
Common Stock
2025-08-18$5.07/sh+2,554$12,949→ 83,935 total
Exercise/Conversion
Common Stock
2025-08-18$5.48/sh+547$2,998→ 85,576 total
Exercise/Conversion
Common Stock
2025-08-18$2.74/sh+4,744$12,999→ 90,867 total
Exercise/Conversion
Common Stock
2025-08-18$3.16/sh+1,094$3,457→ 91,961 total
Sale
Common Stock
2025-08-18$6.70/sh−7,722$51,737→ 86,558 total
Exercise/Conversion
Common Stock
2025-08-18$5.21/sh+547$2,850→ 86,123 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-08-18−547→ 0 total
Exercise: $5.48Exp: 2026-10-26→ Common Stock (547 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-08-18−4,744→ 0 total
Exercise: $2.74Exp: 2028-02-21→ Common Stock (4,744 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-08-18−1,094→ 0 total
Exercise: $5.48Exp: 2026-04-11→ Common Stock (1,094 underlying)

Footnotes (3)

[F1]On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options.
[F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]This option is fully vested.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Aura Biosciences, Inc.

CIK 0001501796

Entity typeother

Related Parties

1

filerCIK 0002042910

Filing Metadata

Form type: 4
Filed: Aug 17, 8:00 PM ET
Accepted: Aug 18, 4:34 PM ET
Size: 29.1 KB

View on SEC.gov